IQV - IQVIA HOLDINGS INC.


150.28
-0.400   -0.266%

Share volume: 1,333,064
Last Updated: 04-25-2025
Business Services/Services – Research, Development, Testing Labs: -0.08%

PREVIOUS CLOSE
CHG
CHG%

$150.68
-0.40
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
48%
Profitability 31%
Dept financing 50%
Liquidity 13%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
4.64%
1 Month
-16.21%
3 Months
-27.40%
6 Months
-30.92%
1 Year
-36.18%
2 Year
-18.17%
Key data
Stock price
$150.28
P/E Ratio 
25.98
DAY RANGE
$145.90 - $150.86
EPS 
$7.57
52 WEEK RANGE
$135.97 - $252.88
52 WEEK CHANGE
-$36.18
MARKET CAP 
35.667 B
YIELD 
N/A
SHARES OUTSTANDING 
182.300 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.63
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,014,990
AVERAGE 30 VOLUME 
$2,356,514
Company detail
CEO: Ari Bousbib
Region: US
Website: iqvia.com
Employees: 86,000
IPO year: 2013
Issue type: Common Stock
Market: NYSE
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services. The Research & Development Solutions segment provides project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services.

Recent news
loading